Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.
Pae
Chi-Un
CU
Kim
Jung-Jin
JJ
Lee
Chang-Uk
CU
Chae
Jeong-Ho
JH
Lee
Soo-Jung
SJ
Lee
Chul
C
Paik
In-Ho
IH
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003511:Cyclohexanols / Q000009:adverse effects* / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy / Q000378:metabolism; D003987:Dibenzothiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005687:Galactorrhea / Q000139:chemically induced*; D006801:Humans; D011388:Prolactin / Q000378:metabolism; D000069348:Quetiapine Fumarate; D000069470:Venlafaxine Hydrochloride
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D003511:Cyclohexanols; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; D000069470:Venlafaxine Hydrochloride; D011388:Prolactin